Publicaciones en colaboración con investigadores/as de Hospital del Mar (29)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370

  3. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2291-2296

2022

  1. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2677-2699

2020

  1. Recommendations for the diagnosis and treatment of clostridioides difficile infection: An official clinical practice guideline of the spanish society of chemotherapy (SEQ), spanish society of internal medicine (SEMI) and the working group of postoperative infection of the spanish society of anesthesia and reanimation (SEDAR)

    Revista Espanola de Quimioterapia, Vol. 33, Núm. 2, pp. 151-175

2019

  1. Recommendations from a panel of experts on the usefulness of fidaxomicin for the treatment of infections caused by Clostridium difficile

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 1, pp. 50-59

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

  2. Dalbavancin in the treatment of different gram-positive infections: a real-life experience

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577

2017

  1. Caracterización y control rápido de un brote de Enterococcus faecium resistente a vancomicina en una unidad de trasplantados renales en España: el ambiente importa

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 1, pp. 5-11

  2. Systematic therapeutic drug monitoring for linezolid: Variability and clinical impact

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 10

2016

  1. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 8, pp. 2125-2130

  2. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

2014

  1. Ceftarolina, un nuevo antimicrobiano de amplio espectro en la era de las multirresistencias

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. SUPPL. 2, pp. 1-7

  2. Pandemic influenza A (H1N1) in non-vaccinated, pregnant women in Spain (2009-2010)

    Maternal and Child Health Journal, Vol. 18, Núm. 6, pp. 1454-1461

  3. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy

    Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326

  2. Coste de la diarrea asociadaa clostridium difficile en España

    Revista Espanola de Salud Publica, Vol. 87, Núm. 1, pp. 25-33

  3. Inappropriate use of antibiotics in hospitals: The complex relationship between antibiotic use and antimicrobial resistance

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. SUPPL. 4, pp. 3-11

  4. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183